The FDA has labeled this as a Class I recall, which means using these devices can lead to significant injuries, including death.

Findings from the SOLVE-CRT study were presented to attendees at Heart Rhythm 2023. "Our results showed the study was safe, effective and feasible," Singh said. 

The two companies first started collaborating on diabetes technology in 2021. The acquisition is not yet final, but Novo Nordisk now holds the exclusive negotiation rights.

These latest cuts could be a "breaking point" for physicians, according to a new letter to lawmakers. 

Heart Rhythm 2023 in New Orleans brought together EP experts from all over the world. Scroll through a large selection of photos from the big event. 

"The goal is to treat patients with life-threatening VT in a safer, faster and better way," one researcher explained.

There are now numerous AI algorithms for electrophysiology. Jagmeet Singh, MD, examined how this advanced technology is being applied.

Daniel Cantillon, MD, explained why the positive performance of Abbott's Aveir dual-chamber leadless pacemaker could lead to considerable improvements in patient care. 

The Improving Care and Access to Nurses Act aims to let APRNs practice “to the full scope of their education and clinical training.”